CME Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and… Thomas Sullivan Oct 12, 2024 0 This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key…
CMS HHS Endorses Telehealth Accreditation Programs Thomas Sullivan Oct 11, 2024 0 In September of 2024, the U.S. Department of Health and Human Services (HHS) published its stamp of approval for telehealth…
Medical Legal Wholesale Drug Distributor Owners Indicted for Alleged Counterfeit HIV… Thomas Sullivan Oct 10, 2024 0 Owners of a wholesale drug distributor were recently indicted in the Southern District of Florida for alleged engagement in a…
Drug Prices Congressional Budget Office Releases: Alternative Approaches to Reducing… Thomas Sullivan Oct 10, 2024 0 As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived…
Global Global Update on Transparency Reporting: Key Changes and Compliance… Thomas Sullivan Oct 8, 2024 0 In a recent global compliance presentation at the Informaconnect Transparency, Aggregate Spend and HCP Engagement, Elan…
Medical Legal SCOTUS Rejects Chevron Deference Thomas Sullivan Oct 7, 2024 0 On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright…
Affordable Care Act CMS Issues Enforcement Report on NSA and ACA Thomas Sullivan Oct 4, 2024 0 The United States Centers for Medicare and Medicaid Services (CMS) Center for Consumer Information and Insurance Oversight…
False Claims Act DOJ Announces False Claims Act Settlement with Hospice Care Company… Thomas Sullivan Oct 3, 2024 0 Intrepid USA, along with several whole-owned subsidiaries, recently reached a $3.85 million settlement with the United States…
Anti Kickback DOJ Announces $8.8 Million FCA and AKS Statute Settlement with NIRP Thomas Sullivan Oct 2, 2024 0 The United States Department of Justice (DOJ) and National Interventional Radiology Partners (NIRP) recently announced an $8.8…
FDA OPDP Sends Untitled Letter to AbbVie Over Ubrelvy Television Ad Thomas Sullivan Oct 1, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter…